We invite you to register for the Cutting Edge Medicine™ Immunology Online: The Emerging Role of Immunologic Therapies CME Program

Program Overview:

Presenters from the 2009 Cutting Edge Medicine™ Immunology Symposium:  The Emerging Role of Immunologic Therapies were videotaped to provide physicians from across the country with the opportunity to benefit from the information and dialogue that took place at the May 1, 2009, meeting in New York, New York. This multidisciplinary continuing medical education (CME) program addresses the fact that although there is a proliferation of new therapies designed to inhibit specific immune responses in chronic inflammatory diseases, many clinical subspecialties that are not traditionally immunologically oriented, such as gastroenterology, neurology, and dermatology, are faced with the difficult task of understanding the immunologic basis of disorders within their fields in order to best utilize new biologic therapies in practice.

Each presentation is 30 minutes long, followed by a panel discussion in each of the 4 main specialty groups: rheumatology, gastroenterology, neurology, and dermatology—plus a bonus Immunology Update presentation. Watch one or all 5 topics!

Learning Objectives 

The information presented at this educational activity should improve your ability to:

·         Assess the impact of new therapies on cytokines, T cells, and B cells

·         Identify patients who are appropriate candidates for treatment incorporating these new therapies

·         Utilize new drug therapies targeting the human immune system for the treatment of various diseases, including inflammatory bowel disease, rheumatic diseases, multiple sclerosis, and psoriasis

Target Audience

This activity is intended for office- and hospital-based gastroenterologists, rheumatologists, neurologists, and dermatologists.

Accreditation/Continuing Education Credit for Physicians

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of The School of Medicine of The University of North Carolina at Chapel Hill and MedEDirect. The School of Medicine of The University of North Carolina at Chapel Hill is accredited by the ACCME to provide continuing medical education for physicians.

Credits

The School of Medicine of The University of North Carolina at Chapel Hill designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Jointly sponsored by The School of Medicine of The University of North Carolina at Chapel Hill and MedEDirect.

The program is supported through unrestricted educational grants from

Bristol-Myers Squibb, Centocor, and Genentech Inc.